Antibe Provides April 2023 Corporate Update

TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies to target inflammation, is pleased to provide a corporate update. CRO Selected for PK/PD Study for Otenaproxesul’s New Formulation Further to Antibe’s update of February 15, 2023, the Company has now selected a clinical … [Read more…]

Global Oral Solid Dosage Manufacturing Market to 2035: by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area and Key Geographical Regions – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Oral Solid Dosage Manufacturing Market – Distribution by Type of Finished Dosage Form, Type of Packaging, Scale of Operation, Company Size, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” report has been added to ResearchAndMarkets.com’s offering. This report features an extensive study of the current market landscape and future … [Read more…]

Rockwell Medical to Exhibit at the National Kidney Foundation SCM23

WIXOM, Mich.–(BUSINESS WIRE)–$RMTI #EndStageKidneyDisease–Rockwell Medical, Inc. (the “Company”) (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company is exhibiting its hemodialysis concentrates portfolio in Booth #503 at the National Kidney Foundation Spring Clinical Meetings, which will be held April 11-15, … [Read more…]

Jim Bob Ward Appointed as Chief Strategy Officer at eClinical Provider Crucial Data Solutions

RENO, Nev.–(BUSINESS WIRE)–#blockchain–Crucial Data Solutions (CDS), a provider of innovative technologies to advance clinical research, announced today that industry veteran Jim Bob Ward has joined the company as Chief Strategy Officer. In this newly created role, Ward will continue to refine and execute on CDS’ strategic vision for its eClinical platform, TrialKit, by applying his … [Read more…]

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

DSMC finds no safety concerns, allows use of highest dose for continued administration. Interim analysis of the trial expected in next month Company opens Spanish subsidiary to lead EU clinical trials ATLANTA–(BUSINESS WIRE)–Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with … [Read more…]

U.S CT (Computerized Tomography) Market Outlook Report, 2022-2025: Featuring Leading Players GE, Philips, Siemens, Canon, Fujifilm, Bayer, Bracco, Guerbet, and more – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2022 U.S CT Market Outlook Report” report has been added to ResearchAndMarkets.com’s offering. This 2022 CT Market Outlook Report summarizes the results of the Medical Information Division’s 2022 survey of U.S. hospitals and Independent Imaging Centers that perform CT procedures using fixed CT scanners and provide a summary of the CT medical imaging … [Read more…]

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

ST. PETERSBURG, Fla.–(BUSINESS WIRE)–PathO3Gen Solutions multi-patented UVZone® shoe sanitizing technology is proven to eliminate Candida auris up to 99.9993% in 10 seconds. The Centers of Disease Control (CDC) continues reporting on the Candida auris outbreak, a potentially deadly fungus which causes severe illness for long-term care and long-term hospitalized patients, such as those in nursing … [Read more…]

Genexine’s Long-acting Anemia Treatment GX-E4 Phase 3 Clinical Trial Interim Result Is Presented at WCN2023, Confirmed Non-inferiority Compared to Mircera

SEOUL, South Korea–(BUSINESS WIRE)–A clinical-staged proprietary platform technology biotech company Genexine (KQ 095700, CEO Neil Warma) and its Asian regional partner, KG Bio unveiled the interim results of phase 3 clinical trial of GX-E4 (Efepoetin alfa), a candidate for CKD (Chronic Kidney Disease) induced anemia. Its non-inferiority results compared to Mircera (Methoxy Polyethylene Glycol-epoetin beta) … [Read more…]

U.S Nuclear Medicine Market Outlook Report 2022-2024 Featuring Siemens, GE, Philips, Canon, Digirad, Spectrum Dynamics and more – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2022 U.S Nuclear Medicine Market Outlook Report” report has been added to ResearchAndMarkets.com’s offering. The 2022 Nuclear Medicine Market Outlook examines nuclear medicine procedure volumes, purchase plans, and buying criteria for future nuclear medicine purchases. Learn how NM administrators feel about their department’s future outlook and how they prioritize their goals in light … [Read more…]

FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis

Implantable shock absorber (ISA) relieves pain and improves function in people ineligible for, or unwilling to undergo, joint replacement MISHA Knee System is implanted during an outpatient procedure; it’s the first and only device of its kind for people with symptomatic knee OA More than 32 million people in the United States are affected by … [Read more…]